Akorn, Inc. is recalling approximately 744 tubes of Sodium Chloride Ophthalmic Ointment USP, 5% sold under the Akorn, Well at Walgreens, and CVS Health brands. The recall was initiated because brown spots were found on the inside of the tubes, which were identified as particles of tin and copper from the materials used to construct the tube. These metal particles can contaminate the ointment, potentially leading to eye irritation or injury for those using the product. The affected tubes were distributed nationwide across the United States and Puerto Rico.
The presence of metal particulates like tin and copper in an eye ointment can cause physical irritation, inflammation, or injury to the surface of the eye when the product is applied.
Return unused product to the pharmacy for a refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.